fitoestrogeni
DESCRIPTION
Fitoestrogeni. ER in cell cycle progression. Myc. ER. Cdc25A. CyclinD1 Cdk4. CyclinE Cdk2. E2F. Rb. DNA pol a Cyclins E,A B-Myb. G1. S. Estrogen Receptor. Estrogen Receptors. http://www.bio.cmu.edu/Courses/BiochemMols/ER/#ERchime. Estrogen Receptors. ER- a - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/1.jpg)
FitoestrogeniFitoestrogeni
![Page 2: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/2.jpg)
![Page 3: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/3.jpg)
![Page 4: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/4.jpg)
DNA pol a
Cyclins E,A
B-Myb
![Page 5: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/5.jpg)
Estrogen Receptor
![Page 6: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/6.jpg)
Estrogen Receptors
http://www.bio.cmu.edu/Courses/BiochemMols/ER/#ERchime
![Page 7: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/7.jpg)
Estrogen Receptors• ER-
– Uterus, testis, pituitary, ovary, epididymis, and adrenal gland.
• ER- (Kuiper et al. 1996)– brain, kidney, prostrate, ovary, lung, bladder, intestine, and
epididymis.– 88% identity with rat ER-
identity with human ER-
• Membrane localized ER (Pietras and Szego, 1997)
• ER and differ in C-terminal ligand binding domains and N-terminal transactivation domains. Highest homology in DNA binding domain.
![Page 8: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/8.jpg)
![Page 9: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/9.jpg)
Regulation of ER activity by coactivators and corepressors
![Page 10: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/10.jpg)
![Page 11: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/11.jpg)
Hall et al. 2001. J. Biol. Chem., 276: 36869-36872
![Page 12: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/12.jpg)
ER effects on different cell types
![Page 13: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/13.jpg)
Estrogen has multiple effects
![Page 14: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/14.jpg)
![Page 15: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/15.jpg)
Ligand Induces a Conformational Change in the LBD that Repositions helix 12
No Ligand Agonist
![Page 16: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/16.jpg)
NR Antagonists Alter the Position of Helix 12
No Ligand Agonist(ER)
Antagonist(ER)
![Page 17: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/17.jpg)
![Page 18: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/18.jpg)
Phytoestrogens
Aherne and O’Brien, 2002. Nutrition 18:75-81.
![Page 19: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/19.jpg)
Benassayag, et al., 2002. J. Chromatogr.B 777:233-248.
![Page 20: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/20.jpg)
Comparison of binding affinities and transactivation of estrogen and phytoestrogens
Belcher & Zsarnovszky, 2001. J. Pharmacol. Exp. Therap. 299:408-414
![Page 21: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/21.jpg)
Dietary Sources of Phytoestrogens
![Page 22: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/22.jpg)
Pytoestrogens in humans• Fitoestrogeni hanno una attivita’ piu’ debole di quella degli
estrogeni circolanti (17--estradiol or estrone).• Fitoestrogeni possono legarsi alla sex steroid binding
protein (SBP) e -feroprotein (AFP) e circolare.• Fitoestrogeni sono coniugati nel fegato (da
sulfotransferasi and UDP-glucoronyosyl transferasi), circolano nel plasma ed escreti nelle urine.
• Livelli di Fitoestrogeni sono piu’ alti nei fluidi dei dotti prostatici e mammari di quelli del plasma.
• Le urine dei vegetariani possono contenere 1000 volte piu’ Fitoestrogeni che estrogeni totali.
• Fitoestrogeni hanno effetti inibitori a 0.5-50M che sono livelli simili alle urine.
![Page 23: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/23.jpg)
Fitoestrogeni (PEs) della Soia• Genistein, daidzein, coumesterol, and equol si legano e
transattivano ER and (0.1-10M)• Genistetin ha una affinita’ piu’ alta per ER.• Soia PEs influenzano la progressione del ciclo cellulare,
crescita e differenziamento. Hanno attivita’ antiossidanti.
![Page 24: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/24.jpg)
• Antioxidant, anti‑apoptosis, anti‑inflammatory, anti-cancer, and anti‑invasive.• Reduces Cu-induced LDL oxidation by binding to LDL via a glycosidic ether bond. Increases HDL cholesterol. Inhibits platelet activation.• Ameliorates neuronal damage due to ethanol consumption. Probably via antioxidant effect. Minimizes effects of NOS activity by ehtanol. Inhibits ethanol-induced arachidonic acid release and cycloxygenase activity.Anti-ageing role?• inhibitory effects on cancer initiation, growth promotion progression and angiogenesis in model systems. • The anti‑proliferative activity of resveratrol is mediated by p38-MAPKs via p53 mediated inhibition. Resveratrol may inhibit apoptosis induced by oxidized lipoproteins through inhibition of NF-B and AP-1 pathways.• Resveratrol inhibits protein kinase C, Akt, and FAK activities in ER (+) breast cancer cells.
Red wine phytoestrogens:Resveratrol, quercetin, and anthocyanins
![Page 25: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/25.jpg)
Genistein
• Both estrogenic and anti-estrogenic effects
• Inhibitor of tyrosine kinases• 20-fold higher binding affinity for ER-
than ER- (Makela et al. 1999)
Synonyms: 4',5,7-Trihydroxyisoflavone;
Synonyms: 4',5,7-Trihydroxyisoflavone;
Synonyms: 4',5,7-Trihydroxyisoflavone;
4',5,7-Trihydroxyisoflavone
![Page 26: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/26.jpg)
Phytoestrogens in Human Health
• Cancer preventive• Post-menopausal supplement• Prevention of osteoporosis• Cardiovascular health• Fertility• Breast enhancement
References: Kurzer, 2003. J. Nutr. 133: 1983S-1986S.
Benassayag, et al., 2002. J. Chromatogr.B 777:233-248.
![Page 27: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/27.jpg)
Cancer preventive• Benefits to human breast and uterine cancer
controversial.• Genistein can be carcinogenic in uterine cancer at
neonatal exposure.• Cancer protective in animal studies, especially when
exposed during breast development.• Isoflavonoids and lignans stimulate proliferation of ER+
breast cancer cells.• Inhibit cell growth at high concentrations and in ER (-)
breast cancer cells. • Therefore, ER may have cancer protective effect.• Anti-angiogenic effects of genistein, daidzein, and
biochanin A may contribute to antitumor activity.• Anti-oxidants in vitro and in vivo.
![Page 28: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/28.jpg)
Post-menopausal therapy
• In 2002, the Women’s Health Initiative (WHI) trial of estrogen/progestin therapy was halted midtrial due to high incidence of breast cancer and cardiovascular disease.
• Consumption of 30mg/d soy isoflavones may reduce hot flashes by 30-50%.
![Page 29: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/29.jpg)
Prevention of osteoporosis
• Isoflavone intake increases bone mineral density.
• Can be useful in preventing post-menopausal osteoporosis.
• Diets rich in phytoestrogens can protect long-term bone loss (Setchell & Lydeking-Olsen, 2003. Am. J. Clin. Nutr. 78:593S-609S) .
![Page 30: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/30.jpg)
Cardiovascular health
• Average intake of 47g/day soy protein results in 9% decrease in total cholesterol,13% decrease in LDL cholesterol, and a trend towards HDL cholesterol.
• Flavanoids decrease platelet aggregation.• Genistein-induced inhibition of growth factor
activity can interfere with platelet and thrombin action.
![Page 31: Fitoestrogeni](https://reader035.vdocument.in/reader035/viewer/2022070420/56815de2550346895dcc09ed/html5/thumbnails/31.jpg)
Effects on fertility (premenopausal)
• Interferes with menstrual cycle (delay)Reduced LH and FSH and progesterone.• Male rodents exposed to PEs in early life:
impaired semen quality, congenital malformations, testicular cancer
(coumesterol, delay in mating)